Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
Clinical Trials (London, England)|February 4, 2021
COVID-19 vaccine trials: The use of active controls and non-inferiority studiesThomas R Fleming, Philip R Krause, Martha Nason, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57J Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Open Forum Infectious Diseases|July 14, 2023
Early Discontinuation of Antibiotics in Patients Admitted With Clinically Suspected Serious Infection but Negative Cultures: Retrospective Cohort Study of Practice Patterns and Outcomes at 111 US HospitalsSameer S Kadri, Sarah Warner, Chanu Rhee, et al.
Vaccine|March 8, 2024
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trialPeter B Gilbert, Youyi Fong, Nima S Hejazi, et al.
Journal of Virology|September 11, 2009
Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteersYo Hoshino, Harutaka Katano, Ping Zou, et al.
The New England Journal of Medicine|October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in LiberiaStephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2004
Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failureRyotaro Nakamura, Minoo Battiwalla, Scott Solomon, et al.
Critical Care Medicine|October 3, 2022
Epidemiology of ICU-Onset Bloodstream Infection: Prevalence, Pathogens, and Risk Factors Among 150,948 ICU Patients at 85 U.S. HospitalsAurelie Gouel-Cheron, Bruce J Swihart, Sarah Warner, et al.
Journal of Virology|September 16, 2004
Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infectionMichele Di Mascio, Martin Markowitz, Michael Louie, et al.
The Journal of Infectious Diseases|December 23, 2009
CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmissionJean K Lim, David H McDermott, Andrea Lisco, et al.
Pageof 20